Showing results (391-400 of 6,499) with videos related to

Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|September 4, 1999
Generating a T cell tumor-specific immune response in vivo: can flt3-ligand-generated dendritic cells tip the balance?H J McKenna
Cancer Immunology, Immunotherapy : CII|September 4, 1999
Synergistic antitumor effects of interleukin-12 gene transfer and systemic administration of interleukin-18 in a mouse bladder cancer modelK Yamanaka, I Hara, H Nagai, et al.
Cancer Immunology, Immunotherapy : CII|September 4, 1999
An EGP-2/Ep-CAM-expressing transgenic rat model to evaluate antibody-mediated immunotherapyP M McLaughlin, B J Kroesen, W H Dokter, et al.
Cancer Immunology, Immunotherapy : CII|September 9, 1999
Immunoregulation in pancreatic cancer patientsJ M Plate, S Shott, J E Harris
Cancer Immunology, Immunotherapy : CII|January 12, 2000
Biodistribution and tumor localization of lymphokine-activated killer T cells following different routes of administration into tumor-bearing animalsJ Kjaergaard, M E Hokland, R Agger, et al.
Cancer Immunology, Immunotherapy : CII|December 22, 1999
Cancer immunotherapy by antisense suppression of Ii protein in MHC-class-II-positive tumor cellsG Qiu, J Goodchild, R E Humphreys, et al.
Cancer Immunology, Immunotherapy : CII|August 4, 1999
Enhanced antitumor activity of a combination treatment with a mouse/human chimeric anti-MK-1 antibody and lymphokine-activated killer cells in vitro and in a severe combined immunodeficient mouse xenograft modelT Yamamoto, F Arakawa, K Nakamura, et al.
Cancer Immunology, Immunotherapy : CII|August 4, 1999
Efficacy of repeated cycles of chemo-immunotherapy with thymosin alpha1 and interleukin-2 after intraperitoneal 5-fluorouracil deliveryG Silecchia, E Guarino, P Sinibaldi-Vallebona, et al.
Cancer Immunology, Immunotherapy : CII|August 4, 1999
Semiquantitative analysis of Th1 and Th2 cytokine expression in CD3+, CD4+, and CD8+ renal-cell-carcinoma-infiltrating lymphocytesU Elsässer-Beile, T Grussenmeyer, D Gierschner, et al.
Cancer Immunology, Immunotherapy : CII|August 4, 1999
Investigating the lysis of small-cell lung cancer cell lines by activated natural killer (NK) cells with a fluorometric assay for NK-cell-mediated cytotoxicityC Lehmann, B Glass, M Zeis, et al.
Pageof 650